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The formationof newmemories requires new information tobe encoded in the face of proactive interference from thepast. Two solutions
have been proposed for hippocampal region CA1: (1) acetylcholine, released in novelty, selectively suppresses excitatory projections to
CA1 from CA3 (mediating the products of retrieval), while sparing entorhinal inputs (mediating novel sensory information) and (2)
encodingpreferentially occurs at thepyramidal-layer theta peak, coincidentwith input fromentorhinal cortex, and retrieval occurs at the
trough, coincident with input from CA3, consistent with theta phase-dependent synaptic plasticity. We examined three predictions of
thesemodels: (1) in novel environments, the preferred theta phase of CA1 place cell firing should shift closer to the CA1 pyramidal-layer
theta peak, shifting the encoding-retrieval balance toward encoding; (2) the encoding-related shift in novel environments should be
disrupted by cholinergic antagonism; and (3) in familiar environments, cholinergic antagonism should shift the preferred theta firing
phase closer to the theta trough, shifting the encoding-retrieval balance even further toward retrieval. We tested these predictions by
recording fromCA1 pyramidal cells in freelymoving rats as they foraged in open field environments under the influence of scopolamine
(an amnestic cholinergic antagonist) or vehicle (saline). Results confirmed all three predictions, supporting both the theta phase and
cholinergic models of encoding versus retrieval dynamics. Also consistent with cholinergic enhancement of encoding, scopolamine
attenuated the formation of distinct spatial representations in a new environment, reducing the extent of place cell “remapping.”
Introduction
Memory systems need to encode novel information in the face of
interference from previously encoded associations (proactive in-
terference). The hippocampus is crucial tomemory (O’Keefe and
Nadel, 1978; Squire, 1992; Eichenbaum and Cohen, 2001),
thought to act as a comparator identifying novel from familiar
information, with region CA1 playing a key role (Hasselmo et al.,
1996; Vinogradova, 2001; Lisman andGrace, 2005). CA1 receives
input from CA3, thought to convey retrieved information
following recurrent collateral-mediated pattern completion
(McNaughton and Morris, 1987; Treves and Rolls, 1994), and
from the entorhinal cortex, whichmight convey feedforward sen-
sory information. Two sets of models propose solutions to pro-
active interference.
The theta (4–12 Hz) oscillation has been related to the dy-
namics ofmemory function (O’Keefe andNadel, 1978; Jones and
Wilson, 2005; Buzsa´ki, 2006; Huxter et al., 2008; Tort et al., 2009;
Jezek et al., 2011), and specifically to the interplay between en-
coding and retrieval (Hasselmo et al., 2002; Kunec et al., 2005). In
theta-based models, the phase of ongoing theta oscillations tem-
porally separates encoding and retrieval, and determines the dif-
ferent plasticity regimes that encoding and retrieval require.
Encoding in CA1 occurs preferentially at the peak of pyramidal-
layer theta, driven by entorhinal inputs, while CA3-driven re-
trieval preferentially occurs at the theta trough (Hasselmo et al.,
2002). This is consistent with data regarding the timing of ento-
rhinal and CA3 input (Brankack et al., 1993; Colgin et al., 2009;
Mizuseki et al., 2009; Scheffer-Teixeira et al., 2012) andwith theta
phase-dependent synaptic plasticity (Huerta and Lisman, 1995;
Hyman et al., 2003; Kwag et al., 2011).
Related models (Hasselmo et al., 1996; Meeter et al., 2004)
emphasize acetylcholine’s (ACh) role in biasing the encoding-
retrieval balance toward encoding, by enhancing plasticity while
dampening the recurrent CA3 activity mediating the retrieval of
past associations. ACh presynaptically suppresses excitatory,
retrieval-related CA3 inputs onto CA1, while excitatory entorhi-
nal inputs mediating new associations are relatively preserved
(Hasselmo and Schnell, 1994; Dasari and Gulledge, 2011). The
increased cholinergic tone during exploration of novel environ-
ments (Thiel et al., 1998; Giovannini et al., 2001) would thus set
encoding-retrieval dynamics toward encoding. Consistent with
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this, blockade of muscarinic receptors by scopolamine specifi-
cally impairs encoding and increases proactive interference
(Rogers andKesner, 2003; Atri et al., 2004; Antonova et al., 2011).
In these models, theta phase (subsecond timescale) and ACh
(longer timescale) separate pro-encoding and pro-retrieval
states, and schedule them for appropriate synaptic plasticity. We
tested the conjoint predictions (Fig. 1) of thesemodels as follows.
Assuming that encoding-retrieval dynamics is biased toward en-
coding during novelty exposure, CA1-preferred firing phase
should shift closer to the pyramidal-layer theta peak in novelty.
Under the ACh model, scopolamine (a muscarinic antagonist)
would disrupt this shift and further favor retrieval of intrinsic
inputs over encoding of extrinsic inputs, even during exploration
of a familiar environment. Thus, scopolamine should shift pre-
ferred firing phases closer to the pyramidal-layer theta trough.
The present study confirms these predictions, supporting a com-
bination of both models of encoding versus retrieval scheduling
in CA1.
Materials andMethods
Animals
Six naive adult male Lister Hooded rats weighing 330–400 g at the time
of surgeryweremaintained on a 12 h light/dark schedule, lights off at 2:00
P.M. After surgery, they were housed individually and kept at 85% free-
feeding bodyweight. All procedures complied with the Animals (Scien-
tific Procedures) Act 1986.
Surgery
Under deep anesthesia, rats were chronically implantedwithmicrodrives
above dorsal CA1, one per hemisphere. Each microdrive allowed a bun-
dle of four movable tetrodes to be vertically lowered through the brain
after surgery. Tetrodes were constructed from four twisted 25 mHM-
L-coated platinum/iridium (90%/10%) wire (California FineWire). The
implants were positioned at 3.0–4.5 mm behind bregma, and 1.8–3.0
mm lateral to the midline.
Drugs
Saline solution (SAL; 0.9% NaCl) and scopolamine hydrobromide
(SCOP; 0.4 mg/kg bodyweight; Sigma-Aldrich) were injected intraperi-
toneally at a volume of 1 mg/kg. Similar doses of scopolamine have been
shown to reliably impair cognition (e.g., encoding, attention, spatial
memory) with relatively minor effects on locomotion (for review, see
Klinkenberg and Blokland, 2010; Deiana et al., 2011).
Experimental apparatus and procedure
All recording took place in a dimly lit room containing one of three
possible environments. Each environment was positioned on top of a 32
cm high table. The first environment is referred to as “familiar” (FAM)
because the rats were exposed to it during all the recording sessions. It
was a black, wooden, square-walled box (60 60 50 cm) placed on a
black Perspex floor (60  60 cm). Two cue cards (different visual pat-
terns) were displayed on the room walls. The two other environments
were novel (NOV) because the animals were exposed to each of them
only once over the entire experiment. One consisted of a white cylinder
(77 cm diameter, 50 cm height). The floor was made of white-painted
wood, and the wall made ofmetal covered by whitemasking tape. A large
cue card with a different pattern than the two familiar ones was displayed
on a different wall. The other NOV environment was a large open square
platformmade of a transparent Plexiglas sheet (82 82 cm); no cue card
was used. In between trials and during the entire screening period, the
animals were placed in a holding box situated next to the environment.
The recording sessions, one per day, were distributed over three con-
secutive blocks A–C (Fig. 2). Testing time was similar for all rats, the first
trial starting at approximately 2:00 P.M.
Block A comprised 5 consecutive days. On the first 4 d, rats were
exposed to four trials (T1–4) in the FAM environment (walled black
square). After this familiarization, the fifth day consisted of six trials
(T1–6), the first three (T1–3) again conducted in the FAM environment,
while the novel white cylinder (NOV) was introduced in the probe trials
T4–5. Trial T6 reverted to the FAM environment. Thus the rats had 19
exposures over 5 d before exposure to the novel environment. Time of
injection (SAL or SCOP) was always after the end of trial T3. At the
beginning of each trial, rats were placed in the center of the environment,
always facing the same direction. They were allowed to forage for grains
of sweetened rice randomly thrown in the environment approximately
every 30 s. Theywere then removed from the recording environment and
placed in the holding box during the intertrial interval. Each trial lasted
15 min and started 20–25 min after the previous trial. The floor of the
environment was cleaned between each trial using 5% alcohol solution.
Block B followed block A, after a 1 d resting period. It was identical in
procedure to block A, except that the open square platformwas the novel
environment on trials T4–5 of the fifth day, and a rat was injected with
scopolamine if saline was injected in block A, and vice versa. Four rats
experienced the novel square in the NOV  SAL session and the novel
cylinder in theNOV SCOP session, and two rats experienced the novel
cylinder in the NOV SAL session and the novel square in the NOV
SCOP session.
In blockC, two sessionswere run in the familiar environment only to test
the effect of injecting scopolamine (FAM  SCOP) and saline (FAM 
SAL). Both sessions were run at least 5 d after the end of block B. Four rats
were run in a four-trial FAM SAL session, and four rats in a six-trial FAM
 SCOP session (three of whomwere tested in the FAM SAL session one
ormore days previously).Other procedureswere similar to those of Blocks
A and B, with scopolamine or saline injected after trial T3.
Figure 1. Diagram of four predictions regarding the preferred theta phase of firing of CA1
pyramidal cells under manipulations of environmental novelty and/or muscarinic cholinergic
blockade. DATA (from experimental literature): hippocampal ACh levels are higher in novelty
(Thiel et al., 1998; Giovannini et al., 2001), and ACh selectively suppresses excitatory input from
CA3 pyramidal cells onto CA1 pyramidal cells (Hasselmo and Schnell, 1994). The preferred firing
phase (i.e., circular mean phase) of CA1 pyramidal cells occurs after the trough of CA1
pyramidal-layer theta in a familiar environment (baseline; black vertical line). Prediction 1: the
phase in this familiar environment should not be affected by saline (FAM SAL; control con-
dition). Prediction 2: in a novel environment under saline (NOV SAL), preferred theta phase
shifts later, closer to the pyramidal-layer theta peak (blue vertical bar), reflecting increased
levels of entorhinal-driven encoding. Prediction 3: scopolamine, a muscarinic cholinergic an-
tagonist, antagonizes ACh’s presumed role in novelty-elicited suppression of CA3 excitatory
input to CA1, and thus disrupts the later-theta-phase-in-novelty-effect (resulting mean phase
suggestedasno change frombaseline). Prediction4: scopolamine shifts preferredphase earlier,
closer to the theta trough (red vertical bar), by removing baseline cholinergic suppression of the
CA3 projections onto CA1.
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Data acquisition
From approximately 1 week after surgery, tetrodes were gradually low-
ered over days and weeks toward the CA1 pyramidal layer. Once ripples
were observed, tetrodes were not lowered by25maday. Electrophys-
iological screening took place while the rat was on a holding platform
within the testing laboratory. Before recording sessions, screening ses-
sions identified electrodes suitable for pyramidal-layer theta referencing.
Electrophysiological recording was performed as described by (Lever et
al., 2009). Briefly, electrical signals were acquired at 250 Hz (local field
potentials; LFPs) and 50 kHz (single cells) via a 32-channel system (Ax-
ona). They were bandpass filtered at 0.34–500Hz for LFPs and at 300Hz
to 7 kHz for single cells, after having, respectively, been amplified 3000–
8000 and 10,000–20,000 times. Position data were sampled at 50 Hz
using LEDs. Speeds2m/s were discarded, likely due to headmovement
or light reflection.
Histology
Rats were killed with an overdose of sodium pentobarbital and perfused
transcardially with saline solution followed by 4% paraformaldehyde
(PFA) solution. Brains were stored in 4%PFAuntil 2 d before sectioning,
and then transferred to a 30% sucrose solution. Brains were sliced coro-
nally into 40-m-thick sections, which were mounted and stained using
cresyl violet solution.
Data selection and analyses
Theta-phase and spatial correlates of place cell firing were analyzed after
manual off-line discrimination between recorded cells using Tint soft-
ware (Axona). Several criteria were used to isolate a place cell cluster,
mainly the peak-to-trough amplitude and interval, and the 40 ms auto-
correlogram. To be included in the analysis, an isolated cell had to fire
30 spikes with a peak firing rate 1 Hz in the locational field (after
smoothing) in at least one trial.
Theta-phase analyses
The timing of place cell firing with respect to the theta oscillation was
investigated at two levels: the spike ensemble level (i.e., all spikes re-
corded from neighboring tetrodes, or “multi-unit activity”) and the sin-
gle cell level. The spike ensemble level may represent CA1 population
activity from the perspective of downstreamneurons. The single cell level
is typical for analysis of spatial coding and theta-phase precession.
Assigning spikes with a theta phase. All the spikes were referenced to an
LFP 500maway.We refer to all the spikes fromneighboring tetrodes
(i.e.,500m away, same hemisphere) as an ensemble. Typically, more
than one LFP reference was available, so there was more than one LFP
plus spike-ensemble combination available per rat (see below, LFP plus
spike ensemble for selection of themost appropriate one). For brevity, in
the Results section, we refer to a given LFP plus spike-ensemble simply as
an “ensemble.” The recorded LFP signal was filtered using a 6–12 Hz,
251-tap, Blackman windowed, bandpass sinc (sine cardinal) filter. An
analytic signal was then constructed using the Hilbert transform, which
takes the form: sa(tk)  s(tk)  iH [s(tk)], where H specifies the Hilbert
transform, s(tk) is the filtered LFP signal and tk  k where k  1,…,K
and is the inverse of the sampling rate. The phase of the analytic signal,
(tk), gives the phase of the LFP at time tk and each spike was assigned the
phase (tk), if it occurred in the interval [tk/2, tk/2]. The positive
theta peak was assigned the 0°/360° phase, and the theta trough, the 180°
phase. The analytic signal was filtered to remove periods of low quality
LFP by discarding those regions with low signal amplitude. Average am-
plitude was calculated for each cycle in the analytic signal, where the start
of each cycle was defined by those points with analytic phase differences
below. Cycles with amplitude below the 15th percentile in each trial
and the spikes falling within them were discarded.
Theta-power ratio. The LFP theta-power ratio score was calculated as
follows. First, data from each trial were divided into runs where the rat
ran at a speed 5 cm/s for at least 0.5 s. For this theta-power analysis
only, data were excluded such that all trials had the same median speed
(Jeewajee et al., 2008). Then, LFP from all runs in a trial were concate-
nated, zero padded to 219 elements, and Fourier transformed after the
mean was subtracted from the LFP signal for each run. The square mod-
ulus of each Fourier frequency coefficient represents the signal power at
that frequency. The zero padding produces an interpolated discrete Fou-
rier transform that artificially increases the frequency resolution but does
not change the spectral content of the signal in any way. The LFP theta-
power ratio score was calculated as the ratio of average signal power in a
2 Hz band centered on the peak in the power spectrum in the 6–12 Hz
theta frequency range, to the average signal power in the entire spectrum.
Since running produces good theta, and trials are speed normalized by
the median-speed procedure above, the theta-power ratio score should
identify theta sensitivity of an LFP electrode in an unbiased way.
Pyramidal-layer theta referencing. In our previous study of phase
change (Lever et al., 2010), LFP-recording tetrodes were not consistently
located across rats, but were located in different layers. In the present
study, we took care to ensure that as far as possible CA1 place cell spikes
were consistently referenced to theta recorded from the pyramidal layer.
First, during screening before recording sessions, we assigned LFP-
recording channels to electrodes on which high-amplitude ripples were
seen. Second, we sought to establish the range of preferred theta phases
characteristic of spike ensembles referenced to the pyramidal layer. We
did this by selecting, for each rat experimental session, an LFP from a
tetrode with good theta-power ratio from which a high number of place
cell spikes were recorded. All the spikes recorded from the same tetrode
as the LFP and from neighboring tetrodes were referenced to that LFP,
and the preferred phase of the LFP-plus-spike-ensemble combination
was calculated. After removal of one obvious outlier (from a sessionwith,
unusually, only one assigned LFP channel), the mean preferred phase of
all the selected LFP-plus-spike-ensemble combinations in the prema-
nipulation baseline trial (T3) was 229°  28° (mean  SD, n  19
combinations). (For this analysis, a single LFP plus spike ensemble com-
bination was taken from each rat from the four experimental testing
conditions, with the 19 combinations comprising: four from FAM 
SAL, six fromNOV SAL, four fromFAM SCOP, and five fromNOV
 SCOP). This range was very consistent with previous studies careful to
record theta from the CA1 pyramidal layer, which observed mean CA1
place cell preferred phases of 210–250°, i.e., 30—70° after the pyramidal-
layer trough (Csicsvari et al., 1999; Mizuseki et al., 2009; Mizuseki et al.,
2011).
Figure2. Experimental design. Experiment is divided into three blocks, A–C. In blocks A and
B, after familiarization to a single environment, rats are exposed to a novel environment (trials
T4 and T5) interleaved between trials in the familiar environment (trials T1–3, T6). On this
novelty exposure day, rats receive either SAL or SCOP injection after trial T3. In block C, run at
least 5 d after the end of block B, all trials are in the familiar environment, and SCOP or SAL is
injected after trial T3.
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Finally, then, LFP plus spike ensemble combinations were classified as
pyramidal layer-referenced or not depending on whether their baseline
trial (T3) preferred phase fell within or outside the range of the above-
mentioned mean 2 SDs (229° 56°).
LFP-plus-spike-ensemble selection. Given that LFPs might be recorded
from up to four neighboring tetrodes, it was necessary to have a rule to
select the best LFP-plus-spike-ensemble combination available from a
given rat or hemisphere. Our aim was to analyze the LFP-plus-spike-
ensemble combinations with robust theta recorded from the pyramidal
layer, whose spike ensembles showed strong modulation by theta phase.
Accordingly, the best LFP-plus-spike-ensemble combination was thus
selected from each rat or hemisphere, depending on the dataset required
(see below), using the following rule. Averaging over the trials T2–5
(T3–4 for FAM  SAL), we ranked all potential LFP-plus-spike-
ensemble combinations for a given rat or hemisphere according to (1) the
mean number of spikes recorded from the LFP tetrode; (2) themean theta-
phase concentration of the spike ensemble (i.e., length of themean vector r);
and (3) the mean theta-power ratio of the LFP. First we discarded any LFP
trace where the spike count on that tetrode was75% of the highest, then
any LFP-plus-spike-ensemble combination whose phase concentration was
75%of the highest. If therewas still a choice to bemade, the LFP reference
with the highest theta-power ratio was selected.
All selected ensembles were significantly theta modulated (Rayleigh
test p  0.001), so their respective preferred phase (i.e., circular mean
phase) was used to summarize the ensemble phase distribution in a trial.
Phase changes at the ensemble level were investigated using three over-
lapping datasets, the largest of which equated to the entire set of spikes
from all rats in all conditions. From conservative to liberal, these datasets
comprised the following: (1) the selected pyramidal layer-referenced en-
sembles from each rat (i.e., maximum one ensemble per rat), this dataset
is called “best pyramidal layer-referenced”; (2) all the selected pyramidal
layer-referenced ensembles (i.e., maximum two ensembles per rat, one
from each hemisphere), this dataset is called “all pyramidal layer-refer-
enced”; (3) all the ensembles selected when nonpyramidal layer-
referenced ensembles were permitted (i.e., maximum two ensembles per
rat, one from each hemisphere), this dataset is called “no exclusions.”
Table 1 provides a comprehensive summary of the results for each testing
condition using the three overlapping datasets.
The potential importance of using a common theta reference across
conditions and rats is suggested by studies showing that the theta-phase
separation angle between two vertically separated electrodes can vary.
For instance, importantly, Leung (1984) showed that theta-phase sepa-
ration between an electrode located in the alveus (same phase as
pyramidal-layer theta) and an electrode located in the stratum radiatum
was not constant but varied according to the balance, as summarized by
Leung, between atropine-sensitive and atropine-resistant inputs. This is
an important finding relevant to the present study since novelty with
respect to familiarity, and by definition scopolamine with respect to
saline, will change the balance between atropine-sensitive and atropine-
resistant inputs. More recently, Montgomery et al. (2009) showed that
the theta-phase separation angle between electrodes in the CA1 pyrami-
dal layer versus the CA1 radiatum layer, and in the CA1 pyramidal layer
versus the CA3 pyramidal layer were not constant across the different
regions of the maze in an alternation task. The varying phase separation
in the central arm relative to other maze regions in that study could
reflect the greater need for memory retrieval in the central arm. A reason
for consistently using pyramidal-layer theta, as opposed to another stan-
dard reference, is that it is a simple way of ensuring a common theta
reference across a dataset and across studies, given that tetrodes need to
be close to the pyramidal layer to record pyramidal cells and that
pyramidal-layer theta phase is at the same phase as theta in the alveus and
oriens. In summary, given our state manipulations (novel vs familiar,
undrugged vs anticholinergic drugged), it is sensible to report results
using a consistently pyramidal layer-referenced theta across the rats and
conditions. We also report results using all the data, when cells/ensem-
bles not referenced to pyramidal-layer theta are also included.
As far aswe could tell from tetrode-bundlemovement records, changes in
electrode positioning across testing conditions were generallyminimal. Rel-
ative to theNOVSALcondition, average tetrode-bundlemovementupor
downwas as follows (FAM SAL:mode: 0mchange,mean SEM: 14
11mabove,n7 ensembles; FAMSCOP:mode0mchange,mean
20 12mbelow, n 8 ensembles; NOV SCOP: mode: 0m change,
mean 10 22 m below, n 11 ensembles). Each testing condition likely
contains a minority of cells sampled in other testing conditions.
Cell-by-cell analysis. Phase changes at the cell level were investigated
using two overlapping datasets: (1) all the available cells that were refer-
enced to pyramidal-layer theta, this dataset is called “all pyramidal layer-
referenced” and (2) all the available cells regardless of referencing, this
dataset is called “no exclusions.” Thereafter, various selection criteria
were applied to create four categories of analysis, ranging from using all
cells through to applying a minimum-spikes threshold and theta-
modulation threshold (Rayleigh p  0.05). Table 2 provides a compre-
hensive summary of the results for each testing condition using the two
overlapping datasets and four categories of analysis.
Table 1. Ensemble-level analyses of preferred theta-phase changes for the four testing conditions
Ensembles Distribution of ensemble preferred phases
Included
(up to 2
per rat; 1 per
hemisphere) n
Cells
(% total)
Spike count
T3 T4
(% total)
Length
of mean
vector (r)
Reliability
of mean
(Rayleigh p) Mean phase SEM
Phase
change
Paired-samples
Moore test
T3 versus T4T3 T4 T3 T4 T3 T4
FAM SAL Best pyr. layer-referenced 4 47 (72%) 80,245 (79%) 0.87 0.88 0.037 0.032 224° 24° 225° 23° 1° 0.9p0.5
Four rats All pyr. layer-referenced 7 65 (100%) 101,611 (100%) 0.84 0.82 0.003 0.004 231° 16° 232° 17° 1° 0.95p0.90
No exclusion 7 65 (100%) 101,521 (100%) 0.74 0.72 0.015 0.020 233° 21° 233° 22° 0° 0.95p0.90
NOV SAL Best pyr. layer-referenced 6 150 (68%) 118,738 (69%) 0.93 0.79 0.001 0.017 243° 12° 291° 21° 48° p 0.005
Six rats All pyr. layer-referenced 9 181 (83%) 149,684 (87%) 0.91 0.60 0.001 0.036 240° 10° 278° 21° 38° p 0.05
No exclusion 11 219 (100%) 170,818 (100%) 0.69 0.52 0.003 0.047 243° 15° 282° 23° 39° p 0.05
FAM SCOP Best pyr. layer-referenced 4 91 (72%) 79,447 (66%) 0.88 0.96 0.032 0.013 224° 23° 190° 13° 34° p 0.01
Four rats All pyr. layer-referenced 7 111 (88%) 106,949 (89%) 0.88 0.95 0.001 0.001 239° 14° 184° 9° 55° p 0.001
No exclusion 8 126 (100%) 119,655 (100%) 0.65 0.94 0.029 0.001 233° 20° 185° 9° 48° p 0.005
NOV SCOP Best pyr. layer-referenced 5 102 (50%) 81,116 (46%) 0.90 0.33 0.009 N.S. (0.61) 224° 17° 146° 134° 78° 0.1p0.05
Six rats All pyr. layer-referenced 8 121 (59%) 96,626 (55%) 0.89 0.54 0.001 N.S. (0.10) 231° 12° 133° 27° 98° p 0.005
No exclusion 11 206 (100%) 176,555 (100%) 0.62 0.29 0.012 N.S. (0.41) 231° 12° 101° 59° 130° p 0.01
Change of the spike-ensemble preferred theta phases for each testing condition was analyzed using three overlapping datasets (the largest of which is the entire dataset) as follows. Best pyr. layer-referenced, the best LFP-plus-spike-
ensemble combination from each rat, where the LFP tetrode recorded pyramidal-layer theta; all pyr. layer-referenced, the best LFP-plus-spike-ensemble combination from each hemisphere of a rat (thusmaximum two per rat), where the
LFP tetrode recorded pyramidal-layer theta; and no exclusions, the best LFP-plus-spike-ensemble combination from each hemisphere of a rat, regardless of the LFP tetrode’s location. This dataset thus includes all the recorded spike
ensembles. (SeeMaterials andMethods, LFP-plus-spike ensemble selection formore details.) Each analysis is described in terms of the number of ensembles (n), cells, and spikes it includes. Changes in preferred phase between baseline T3
and probe T4 trials were analyzed using paired-sample Moore tests. Reliability of mean preferred phase for a given trial is tested by Rayleigh test for nonuniform circular distribution. Note that the value of the mean preferred phase in the
NOV SCOP condition is consistently unreliable in the probe trial (T4), though it is reliable in the baseline trial (T3). This indicates that changes in preferred phase induced by the combination of novelty and scopolaminewere not coherent
across the different rats.
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Statistical testing
Preferred phases in the first probe trial (T4) were compared with those in
the baseline trial (T3) using the nonparametric paired-samples Moore
test for circularmeans (Moore, 1980; Zar, 1999) or aWatson–Williams F
test (W–W) for circular means of independent samples (Fisher, 1993), as
appropriate. Preferred phase changes were considered to be coherent
when the distribution of the preferred phases in each trial was sufficiently
concentrated around the respective mean, as tested by the Rayleigh test
for nonuniformity (p 0.05). Phase analyses were conducted using the
statistical software programOriana 4 (Kovach Computing Services). Re-
garding circular paired-samples testing, the Moore test was preferred to
the Hotelling test because the latter gave unreliable results with small,
unevenly distributed samples of real and simulated data (i.e., those char-
acteristic of baseline ensemble preferred phases). Accordingly, the Ho-
telling test was only used as a supplement to theMoore’s test for cell-level
testing, where samples had higher n andweremore distributed (see Table
2 for similar results using both Hotelling and Moore’s tests).
Linear t tests (e.g., for rate changes) were independent except where
indicated (paired t). ANOVA tests were across-subjects, except where
indicated (ANOVARM). For t tests and ANOVA, where variances
were unequal, unequal variance correction was applied. Results were
similar to those under assumptions of equal variance. Where Mauch-
ly’s test indicated that the sphericity assumption was violated, Green-
house–Geisser correction was applied, as indicated by correction to
the degrees of freedom. Results were similar to those under assump-
tions of sphericity.
Table 2. Single cell level analysis of preferred theta-phase changes for the four testing conditions
Cell selection Cell count Length of mean vector (r) Mean preferred phase SEM
Phase change significance T3 vs T4Spikes Theta-mod. Samples T3 T4 T3 T4 T3 T4a
FAM SAL
All pyr. layer-referenced No threshold Independent 64 64 0.68 0.70 225° 6° 223° 6° p 0.81 (W–W)
20 / Independent 64 63 0.68 0.72 225° 6° 224° 6° p 0.92 (W–W)
50 p 0.05 Independent 58 59 0.70 0.73 225° 6° 225° 6° p 0.93 (W–W)
50 p 0.05 Paired 57 57 0.71 0.74 227° 6° 224° 6° p 0.30 (Hotelling)
0.5 p 0.1 (Moore)
No exclusion No threshold Independent 64 64 0.64 0.68 225° 7° 222° 6° p 0.79 (W–W)
20 / Independent 64 63 0.64 0.69 225° 7° 224° 6° p 0.89 (W–W)
50 p 0.05 Independent 58 59 0.69 0.71 226° 6° 225° 6° p 0.90 (W–W)
50 p 0.05 Paired 57 57 0.69 0.72 227° 7° 224° 6° p 0.30 (Hotelling)
0.5 p 0.1 (Moore)
NOV SAL
All pyr. layer-referenced No threshold Independent 180 178 0.48 0.38 231° 6° 263° 8° p 0.001 (W–W)
20 / Independent 139 137 0.55 0.45 232° 6° 261° 7° p 0.001 (W–W)
50 p 0.05 Independent 114 104 0.62 0.49 234° 5° 266° 8° p 0.001 (W–W)
50 p 0.05 Paired 60 60 0.69 0.58 234° 6° 268° 8° p 0.001 (Hotelling)
p 0.001 (Moore)
No exclusion No threshold Independent 218 215 0.42 0.26 230° 6° 270° 10° p 0.001 (W–W)
20 / Independent 168 169 0.47 0.27 229° 6° 266° 11° p 0.001 (W–W)
50 p 0.05 Independent 136 131 0.53 0.30 232° 6° 275° 11° p 0.001 (W–W)
50 p 0.05 Paired 76 76 0.54 0.37 230° 8° 273° 12° p 0.001 (Hotelling)
p 0.001 (Moore)
FAM SCOP
All pyr. layer-referenced No threshold Independent 111 111 0.53 0.68 228° 7° 190° 5° p 0.001 (W–W)
20 / Independent 100 108 0.54 0.69 231° 7° 191° 5° p 0.001 (W–W)
50 p 0.05 Independent 82 82 0.63 0.74 232° 6° 190° 5° p 0.001 (W–W)
50 p 0.05 Paired 65 65 0.70 0.80 233° 6° 196° 5° p 0.001 (Hotelling)
p 0.001 (Moore)
No exclusion No threshold Independent 126 126 0.45 0.67 227° 8° 190° 5° p 0.001 (W–W)
20 / Independent 114 123 0.45 0.68 230° 8° 190° 5° p 0.001 (W–W)
50 p 0.05 Independent 93 97 0.52 0.73 231° 7° 188° 5° p 0.001 (W–W)
50 p 0.05 Paired 76 76 0.56 0.77 234° 8° 193° 5° p 0.001 (Hotelling)
p 0.001 (Moore)
NOV SCOP
All pyr. layer-referenced No threshold Independent 115 120 0.42 0.28 234° 9° 120° 13°*** p 0.001 (W-W)
20 / Independent 99 108 0.44 0.26 235° 9° 124° 16°*** p 0.001 (W–W)
50 p 0.05 Independent 72 69 0.55 0.32 239° 8° 132° 15°*** p 0.001 (W–W)
50 p 0.05 Paired 40 40 0.43 0.28 242° 14° 114° 23°* p 0.001 (Hotelling)
p 0.001 (Moore)
No exclusion No threshold Independent 197 205 0.27 0.18 247° 11° 77° 16°*** p 0.001 (W–W)
20 / Independent 167 181 0.30 0.17 253° 10° 75° 18°** p 0.001 (W–W)
50 p 0.05 Independent 126 129 0.40 0.15 255° 9° 65° 23°* p 0.001 (W–W)
50 p 0.05 Paired 80 80 0.32 0.24 269° 14° 50° 19°* p 0.001 (Hotelling)
p 0.001 (Moore)
For each testing condition, phase change was investigated at the cell level using all available cells (no exclusions) or all available cells that could be referenced to pyramidal-layer theta (All pyr. layer-referenced). For each of these datasets,
four analyses are presented using different cell selection criteria. Cell selection becomesmore conservative according to the following: (1)minimumnumber of spikes fired during a trial; (2)minimum theta-modulation (Rayleigh p threshold
p 0.05); 3) whether spike and theta-modulation criteria are met in either one of T3 and T4 (independent samples) or in both trials T3 and T4 (paired samples). The overall distribution of the preferred theta -phases of cells were strongly
clustered around the “&lquote;mean preferred phase” in all conditions (Rayleigh test ps 0.001) except in the probe trial (T4) in the NOV SCOP conditionwhere, relative to the other three testing conditions, some distributionswere not
that far below the significance threshold for the Rayleigh test for nonuniformity (asterisks). For paired samples, both the nonparametric paired-samples Moore test and the parametric Hotelling test were applied, with similar results. aAll
p values for T4 Rayleigh test indicating reliability of mean preferred phase in T4 were p 0.001 except *** p 0.001, ** p 0.01, * p 0.05.
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Spatial firing analyses
Spatial information was calculated in bits/spike according to the formula
in Skaggs et al. (1993) after applying the PxD maximum-likelihood cor-
rection procedure for inhomogeneity of sampling (Burgess et al., 2005).
Directional bins were 15° in size, and locational bins were 2.5 2.5 cm in
size. Boxcar smoothingwas applied, using three directional bins centered
on the current bin for directional smoothing, and 5 5 locational bins
centered on the current bin for locational smoothing. To analyze remap-
ping, locational firing rate maps for the novel environments were first
transformed to the size and shape of the familiar environment as inWills
et al. (2005), then population vector analysis (Leutgeb et al., 2004;
Kjelstrup et al., 2008) was used to provide a measure of the similarity of
spatial firing rate maps between pairs of trials.
Results
Multiple single units were recorded simultaneously with LFPs
from the dorsal CA1 pyramidal layer of six freely foraging rats.
After familiarization to a familiar environment (FAM; at least 4 d
of four 15min trials), theywere tested in four separate sessions: in
the familiar environment after saline injection (FAM SAL); in
a novel environment after saline injection (NOV SAL); in the
familiar environment after scopolamine injection (FAM 
SCOP); and in a novel environment after scopolamine injection
(NOV SCOP), see Materials and Methods.
All test sessions began with three trials (T1–3) in the FAM
environment, and intraperitoneal injection was always given af-
ter T3. This was followed by either a trial (T4) in the FAM envi-
ronment (FAM SAL session) or three trials (T4–6) in the FAM
environment (FAM  SCOP session) or two trials (T4–5) in a
NOV environment and a trial (T6) in the FAM environment
(NOV SAL and NOV SCOP sessions).
In total, 616 CA1 place cells were recorded from the four test
conditions as follows: FAM SAL (n 65, 4 rats); NOV SAL
(n  219, 6 rats); FAM  SCOP (n  126, 4 rats); and NOV 
SCOP (n  206, 6 rats). The timing of place cell firing with
respect to the theta oscillation was investigated at two levels: the
spike ensemble level (i.e., all spikes recorded from neighboring
tetrodes, ormulti-unit activity) and the single cell level. The spike
ensemble level may represent CA1 population activity from the
perspective of downstreamneurons. The single cell level is typical
for analysis of spatial coding and theta-phase precession.We first
describe illustrative ensembles from individual rats in each of the
four test conditions and then proceed to across-rat summary
analyses.
Theta-phase analyses
CA1 ensemble firing theta phase is stable in a familiar
environment before and after saline injection
Ensembles were referenced to CA1 pyramidal-layer theta (360/0°
peak, 180°  trough). Figure 3A shows a portion of raw (blue
line) and filtered (gray line) theta from one rat recorded during a
baseline trial. Two cycles from the above filtered theta LFP are
used to illustrate the phase reference (Fig. 3B). Figure 3,C andD,
shows, for two rats, the phase distribution of the spike ensembles,
with preferred theta phase occurring at	210–250° in the famil-
iar environment (baseline; black line). The phase distribution is
clearly unaffected by saline injection (brown line).
CA1 ensemble firing shifts closer to the pyramidal-layer theta peak
in a novel environment
Figure 3, E and F, illustrates the “later-theta-phase-in-novelty
effect” in two rats. As in the FAM  SAL session, the preferred
theta phase of an ensemble of CA1 place cell spikes typically
occurred at	210–250° in the familiar environment (black line).
Upon exposure to a novel environment, the distribution of spikes
(blue line) shifted to a later phase, closer to the pyramidal-layer
theta peak (e.g., preferred phase of 281° in Fig. 3E, and 350° in Fig.
3F). The phase distribution of spikes upon re-exposure to the
familiar environment (gray line) closely resembles that seen in
the baseline trial (black line). This later-theta-phase-in-novelty
effect occurred whether the novel environment elicited very sim-
ilar (Fig. 3E) or fewer (Fig. 3F) numbers of spikes compared with
the familiar environment.
CA1 ensemble firing in a familiar environment shifts closer to the
pyramidal-layer theta trough under scopolamine
Figure 3G illustrates how scopolamine injection shifts the phase
distribution of spike firing in a familiar environment to an earlier
phase, closer to the pyramidal-layer theta trough. The preferred
phase in the trial immediately following scopolamine injection
(FAM  SCOP1) was 209°, compared with 252° in the baseline
trial. As scopolamine wore off, the preferred phase gradually ap-
proached that of the baseline trial (FAM SCOP2: 216°; FAM
SCOP3: 244°). Figure 3H shows similar results in another rat,
where the session was extended by another three trials. The pre-
ferred phase was 193° in the trial immediately following scopol-
amine injection (FAM  SCOP1), compared with 245° in the
baseline trial, and progressively approached that of the baseline
trial (FAM  SCOP3: 211°; FAM  SCOP6: 231°). The gradual
return toward baseline in this rat following the scopolamine-
induced shift to an earlier phase is usefully visualized in Figure 4,
which displays absolute preferred phase values for each of trials
T3–T9.
The shift of ensemble firing phase in a novel environment is
disrupted by scopolamine
Figure 3, I and J, illustrates how scopolamine disrupts the later-
theta-phase-in-novelty effect. Despite the exposure to novelty,
the preferred phase did not shift later in the theta cycle. In fact,
for these two rats, the preferred phase is earlier than in the famil-
iar environment. However, preferred phase in this condition is
rather variable across rats (see below and Fig. 5).
Ensemble analyses confirm the later firing phase in novelty,
its disruption by scopolamine, and the earlier phase under
scopolamine in familiarity
We tested the reliability of the above effects over thewhole dataset
by using the paired-samples Moore test (Moore, 1980; Zar,
1999). We focused on the comparison between the baseline trial
T3 and the first probe trial T4. In the ensemble-level analysis,
each trial’s theta-phase distribution of spikes was represented by
the ensemble’s preferred phase (all Rayleigh ps0.001). For sim-
plicity, the results described below are for the best pyramidal
layer-referenced analysis. Table 1 comprehensively documents
the similar results obtained under less conservative analyses.
In the familiar environment, saline injection did not signifi-
cantly shift ensembles’ preferred phase (nonsignificant net phase
change:1°: mean SEM: T3: 224° 24°, T4: 225° 23°; n
4 rats; Moore: R
  0.26, 0.9p 0.5; phase concentration: T3:
p 0.037, T4: p 0.032, Rayleigh test). However, exposure to a
novel environment under saline shifted themean preferred phase
of the ensembles later, that is, toward the pyramidal-layer theta
peak (significant coherent phase change: 48°: T3: 243°  12°,
T4: 291°  21°; n  6 rats; Moore: R
  1.29, p  0.005; phase
concentration: T3: p 0.001, T4: p 0.017). In contrast, scopol-
amine injection in a familiar environment shifted the ensemble
mean preferred phase earlier, toward the pyramidal-layer theta
trough (significant coherent phase change:34°: T3: 224° 23°,
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T4: 190°  13°; n  4 rats; Moore: R
  1.20, p  0.01; phase
concentration: T3: p  0.032, T4: p  0.013). Finally, when in-
jected before exposure to novelty, scopolamine disrupted the
shift to a later theta phase observed under novelty (nonsignifi-
cant, noncoherent net phase change: 78°: T3: 224°  17°, T4:
146° 134°; n 5 rats; Moore: R
  1.02; 0.1p 0.05; phase
concentration: T3: p 0.009, T4: p 0.61).
Importantly, differences in preferred theta phase were not due
to changes in phase concentration.We calculated a concentration
change index as [T4  T3]/[T3  T4] for r, the length of the
mean vector. Concentration change values were rather similar
across manipulations (all available rats/sessions: mean  SEM:
FAM  SAL: 0.013  0.021; NOV  SAL: 0.097  0.116;
FAM SCOP:0.023 0.124; NOV SCOP:0.006 0.228;
ANOVA: F(3,15) 0.09, p 0.97; four rats common to all noncon-
trol conditions: NOV  SAL: 0.003  0.058, FAM  SCOP:
0.023  0.124, NOV  SCOP: 0.079  0.280; ANOVARM:
F(1.02,3.05) 0.11, p 0.77).
The effects of the fourmanipulations in thewhole datasetmay
be best visualized by plotting the preferred theta phase of each
ensemble in each trial with respect to the baseline trial (T3), as
shown in Figure 5. Ensemble preferred phases are normalized to
Figure 3. CA1 ensembles show later preferred firing phases in novelty, an effect disrupted by scopolamine, and showearlier firing phases under scopolamine in familiarity. Examples of the firing
phase distributions of CA1 ensembles in individual rats.A, Raw (blue) and filtered (6–12Hz; gray) LFP trace recorded fromCA1pyramidal-layer showing approximately six theta cycles.B, Two theta
cycles from trace inA are shown for illustrative purposes as the theta reference for the spike phase distributions below. C,D, The preferred phase is very stable in the familiar environment before and
after saline injection (FAM SAL). E, F, Novelty (NOV SAL) elicits a later preferred phase compared with the baseline familiar trial T3 (FAMPre), but the distribution reverts to baseline on return
to the familiar environment (FAMPost). G,H, Scopolamine elicits an earlier preferred phase in the familiar environment (FAM SCOP), then the phase progressively approaches baseline phase as
drug wears off over three (G) or six (H ) sessions. I, J, Scopolamine blocks the novelty-induced later firing phase (NOV SCOP).
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0° in baseline T3, and those in trials T2–6 are rotated accordingly
(rotated preferred phases, see Lever et al., 2010). (Thus, a pre-
ferred phase near 0° in this figure does not correspond to maxi-
mal firing at the pyramidal-layer theta peak, but indicates
similarity to the baseline trial phase.) Figure 5A shows that the
ensemble-preferred theta phases in the familiar environment
were remarkably stable across the premanipulation baseline trials
(T2–3), and clearly unaffected by saline injection (nonsignificant
net change:2° in T4; phase concentration: T4: p 0.008, Ray-
leigh test). However, in the novel environment under saline, en-
semble firing phases shifted to a later theta phase (significant,
coherent phase change: 46° in T4, 42° in T5; phase concen-
tration T4: p 0.008, T5: p 0.011; Fig. 5B), and were remark-
ably stable across the premanipulation baseline trials (T2–3) and
upon return to the familiar environment (T6). Figure 5C shows
that ensemble-preferred firing phases in the familiar environ-
ment shifted to an earlier theta phase immediately following sco-
polamine injection (significant coherent phase change: 34° in
T4; phase concentration T4: p 0.012), and then approached the
baseline phase as scopolamine wore off (30° in T5,16° in T6;
phase concentration T5: p  0.013, T6: p  0.009). Ensemble
phases were stable across the premanipulation baseline trials
(T2–3). Figure 5D illustrates that ensemble-preferred firing
phases under scopolamine did not shift to a later theta phase
despite the exposure to novelty. In fact, the absolute preferred
phase in novelty (T4, T5) was earlier but by a variable amount
across rats (nonsignificant, noncoherent, net phase change: T4:
68°, phase concentration: p 0.35; T5:49°, phase concentra-
tion: p 0.28). We discuss the potential cause for this variability
(see Discussion). Here, we note that one ensemble’s preferred
phases across the premanipulation baseline trials (T2–3) were
not as stable as those seen in the three other testing conditions.
The distribution of phases upon return to the familiar environ-
ment (T6) appeared bimodal, with three rats showing a return to
the baseline phase, and two rats showing an earlier phase, perhaps
reminiscent of the incomplete wearing off of scopolamine in the
FAM SCOP condition (Fig. 3G,H).
Referencing ensemble phase to the premanipulation baseline
trial (T3) enabled us to specifically compare the effect of the
novelty manipulation under saline to that under scopolamine.
Here, putting to one side the issue of the variability of the novelty
plus scopolamine responses, we directly compared the normalized
T4 ensemble preferred phase values for the two novelty conditions.
This confirmed that scopolamine disrupted the later-phase-in-
novelty effect characteristic of the undrugged state (T4–T3:NOV
SAL:46° 18°,n 6 rats;NOV SCOP:68° 45°,n 5 rats;
W–Wtest:F(1,9) 8.48, p 0.017). This disruption is also seenwith
more liberal ensemble inclusion criteria (W–W test: all pyramidal
layer-referenced: p 0.001; no exclusions: p 0.005).
Single cell analyses confirm the later firing phase in novelty,
its disruption by scopolamine, and the earlier phase under
scopolamine in familiarity
Analysis of spiking activity with respect to theta in individual cells
showed similar results to those at the ensemble level. Below, we
report results for all cells with theta-modulated firing (Rayleigh
p  0.05) and with 50 spikes in trial T3 or T4 provided they
were from an ensemble referenced to a pyramidal-layer LFP. Re-
sults were similarwith other criteria (see Table 2). Figure 6 shows,
for each session, the distribution of preferred theta phases of
individual cells in the premanipulation baseline trial (T3,
FAM) and first probe (T4) trials. In all four sessions, the mean
preferred firing phase in the baseline trial was in the 220–240°
range (i.e., 40 –60° after the pyramidal-layer theta trough),
consistent with previous reports of the preferred phase of CA1
pyramidal cells (Csicsvari et al., 1999; Mizuseki et al., 2009;
Mizuseki et al., 2011).
Figure 6A illustrates that saline injection in the familiar envi-
ronment did not change cells’ preferred phase (nonsignificant net
change:1°: T3: 225° 6°, n 58; T4: 224° 6°, n 59; W–W
test: F(1,115) 0.01, p 0.93; phase concentrationT3: p 0.001,
T4: p 0.001, Rayleigh tests). Figure 6B shows examples of three
individual cells. In contrast, environmental novelty under saline
(Fig. 6C) shifted the preferred theta phase of cells later, that is,
toward the pyramidal-layer theta peak (significant coherent
phase change: 32°: T3: 234° 5°, n  114; T4: 266°  8°, n 
104; W–W test: F(1,216) 13.38, p 0.001; phase concentration:
T3: p 0.001, T4: p 0.001; Fig. 6D shows examples). Figure
6E illustrates that in a familiar environment, scopolamine in-
jection shifted preferred phase earlier, toward the pyramidal-
layer theta trough (significant coherent phase change: 42°:
T3: 232° 6°, n 82; T4: 190° 5°, n 82; W–W test: F(1,162)
 28.28, p  0.001; phase concentration: T3: p  0.001, T4:
p  0.001; Fig. 6F shows examples). When administered be-
fore exposure to novelty, scopolamine clearly disrupted the
coherent shift to a later theta phase in novelty characteristic of
the undrugged state. This combined manipulation resulted in
a multipeaked distribution of preferred phases (Fig. 6G), with
an earlier phase overall (significant coherent phase change:
107°; T3: 239°  8°, n  72; T4: 132°  15°, n  69; W–W
test: F(1,139) 53.83, p 0.001; phase concentration: T3: p
0.001, T4: p  0.001; Fig. 6H shows examples).
The between-condition differences in theta-phase preference
as a result of the manipulations were not driven by differences in
spike phase concentration of the cells. We analyzed this in two
ways by using a concentration change index of the means for
trials T3 and T4 ([T4  T3]/[T3  T4]) at the cell level or rat
level. First, phase concentration change indices at the cell level did
Figure 4. Example of scopolamine eliciting earlier preferred phase in the familiar environ-
ment, and progressive return toward baseline phase as drug wears off. In one rat (rat 22, see
also Fig. 3H ), the FAM SCOP session was extended by three trials (i.e., 9 trials in total),
permitting observation of the drug effect wearing off. Preferred phase following scopolamine
injection (T4, T5) is 50° earlier than baseline (T3) phase, then incrementally approaches
(T6–T9) the baseline phase.
8696 • J. Neurosci., May 15, 2013 • 33(20):8689–8704 Douchamps et al. • Theta Phase and ACh Control Encoding-Retrieval
not differ across the three conditions (mean SEM for NOV
SAL: 0.00 0.03, n 60; FAM SCOP:0.09 0.03, n 65;
NOV SCOP: 0.00 0.04, n 40; ANOVA: F(2,164) 2.21, p
0.11). Second, the phase concentration change indices were not
significantly different when compared at the rat level (for the four
rats tested in all three noncontrol testing conditions) when con-
sidering cells that were theta modulated and fired50 spikes in
both trials T3 and T4 (mean  SEM for NOV  SAL: 0.04 
0.05; FAM SCOP:0.11 0.06;NOV SCOP:0.02 0.09;
ANOVARM: F(2,6) 0.54; p 0.61) or all the cells (mean SEM
forNOVSAL: 0.020.04; FAMSCOP:0.170.05;NOV
SCOP:0.12 0.15; ANOVARM: F(2,6) 1.85, p 0.24).
In summary, cell-level analyses showed a similar pattern of
results to the ensemble-level analyses. Novelty elicited a later
theta phase of firing, an effect disrupted by scopolamine. This
result was consistent with scopolamine eliciting an earlier theta
phase in the familiar environment, that is, producing an effect
opposite to the effect of novelty.
Figure 5. Ensemble-level analyses show a later firing phase in novelty, which is disrupted by scopolamine, and an earlier firing phase under scopolamine in familiarity. To simplify
visualizing all testing conditions together, the absolute value of each ensemble’s preferred phase is normalized to premanipulation baseline trial (T3), by rotating ensemble-preferred
phases for each session/rat such that preferred phase in T3 0°. In each trial, the across-rat mean of the preferred phases is shown, if reliable (i.e., Rayleigh test p 0.05), by an arrow
whose length represents r, the concentration of the distribution around the mean (i.e., length of the mean vector; circle radius 1). A, Saline in the familiar environment did not elicit
a change in the preferred phase of firing (FAM SAL: T3 vs T4:2°; Rayleigh T4: p 0.01). B, Environmental novelty induced a coherent later preferred phase of firing (NOV SAL:
T3 vs T4:46°; Rayleigh T4: p 0.01). C, Scopolamine in the familiar environment had an opposite effect to novelty: it induced a coherent earlier phase of firing (FAM SCOP: T3 vs
T4: 34°; Rayleigh T4: p  0.01). D, The novelty-induced shift to a later phase was disrupted by scopolamine (NOV  SCOP); there was no coherent change associated with the
combination of novelty and scopolamine (Rayleigh T4: p 0.35).
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Figure 6. Distributionof each cell’smean thetaphaseof firing shows: a laterphase innovelty,which is disruptedby scopolamine, andanearlier phaseunder scopolamine in familiarity. Left columnsA,C,E,
G, Distributionofmean thetaphase for all selected cells (50 spikes and thetamodulated).B,D,F,H, Left columns show firing ratemaps (maps fromthenovel environments transformed tomatch the shape
andsizeof the familiar environment; spatialpeak rate inHzshownaboveeachplot); right columnsshowspikephasedistributions, forbothbaselineandprobe trials for three representative cells ineachsession.
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Additional analyses: firing rate and running speed do not
account for the phase changes
Firing rate has been hypothesized by some to explain theta-phase
precession, with higher firing rates presumed to drive an earlier
phase under somemodels (Harris et al., 2002;Mehta et al., 2002).
Other studies indicate an independence of phase and rate, or at
least no simple direct relationship (Hirase et al., 1999; Huxter et
al., 2003; Allen et al., 2012; Royer et al., 2012). We investigated if
the later-phase-in-novelty (NOV SAL) and the earlier-phase-
under-scopolamine (FAM  SCOP and NOV  SCOP) effects
could simply be explained by changes in firing rate.We examined
global mean rate and spatial peak rate for theta-modulated cells
firing50 spikes in the baseline and probe trial.
The global firing rate did not differ across the baseline and
probe trials (T3 vs T4) in any of the three testing conditions:
pyramidal layer-referenced: NOV  SAL (T3: 0.78  0.08 Hz,
n  114; T4: 0.64  0.07 Hz, n  104; t(216)  1.40, p  0.16),
FAM SCOP (T3: 0.75 0.09 Hz, n 82; T4: 0.63 0.08 Hz,
n  82; t(162)  1.03, p  0.31) and NOV  SCOP (T3: 0.76 
0.11 Hz, n  72; T4: 0.53  0.07 Hz, n  69; t(139)  1.80, p 
0.07); no exclusions: NOV SAL: (T3: 0.73 0.07 Hz, n 134;
T4: 0.60  0.06 Hz, n  131; t(263)  1.55, p  0.12; FAM 
SCOP (T3: 0.75 0.08 Hz, n 93; T4: 0.59 0.07 Hz, n 97;
t(188) 1.46, p 0.15); NOV SCOP (T3: 0.79 0.08 Hz, n
126; T4: 0.60 0.06Hz, n 129; t(253) 1.92, p 0.06). Though
there was some trend toward reduction, it was common to all
three testing conditions as shown by comparing the average per
rat rate change across the three conditions (pyramidal layer-ref-
erenced: NOV  SAL: 0.16  0.09 Hz, n  6; FAM  SCOP:
0.13 0.11Hz, n 4; NOV SCOP:0.36 0.10Hz, n 5;
ANOVA: F(2,15)  1.56, p  0.25; no exclusions: NOV  SAL:
0.14 0.09 Hz, n 6; FAM SCOP:0.15 0.09 Hz, n 4;
NOV SCOP:0.34 0.11 Hz, n 6; ANOVA: F(2,16) 1.64,
p  0.23). Accordingly, changes in global mean rate cannot ex-
plain the three different patterns of preferred phase changes
caused by the three experimental manipulations.
The average spatial peak rate of the theta-modulated cells fir-
ing50 spikes in trials T3 or T4was reduced by themanipulation
(T3 vs T4), an effect that reached significance in the FAM 
SCOP (T3: 6.3 0.6 Hz, n 82; T4: 4.4 0.4 Hz, n 82; t(142)
2.64, p 0.01) and NOV SCOP (T3: 5.7 0.5 Hz, n 72; T4:
3.6 0.4 Hz, n 69; t(134) 2.30, p 0.02) conditions, but not
in the NOV SAL testing condition (T3: 6.7 0.5 Hz, n 114;
T4: 5.7 0.4 Hz, n 104; t(216) 1.68, p 0.09). Direct com-
parison of the three testing conditions, by comparing the average
per rat rate reduction of the above cells showed that the drop in
spatial peak rate was not significantly different between them
(NOV SAL:1.2 0.8 Hz, n 6; FAM SCOP:2.3 0.5
Hz, n  4; NOV  SCOP: 2.0  0.7 Hz, n  5; ANOVA:
F(2,15) 0.96, p 0.41).
Nevertheless, we considered the potential confound of spatial
peak rate differences as follows. We reanalyzed the cell-level data
restricting analysis to those cells that fired robustly (50 spikes,
theta modulated) in both the baseline (T3) and first probe trial
(T4). Then, cells were ranked by their change of spatial peak rate
from baseline to probe trial (rate change index [T4 T3]/[T3
T4]). The change in spatial peak ratewas then equalized to zero
(0.0) between the three testing conditions by removing cells with
the strongest peak rate reduction. For each testing condition,
we describe results using cells from the all pyramidal layer-
referenced ensembles, and those obtained using all available cells
(no exclusions). Results were similar to the main analyses sum-
marized above and shown in Table 2.
Novelty elicited a significant coherent phase change to a phase
	40–45° later than baseline (all pyramidal layer-referenced: 9
cells removed, n  51 remaining; T3: 233°  7°, T4: 270°  8°;
Moore: R
  2.36, p  0.001; Rayleigh: T3: p  0.001, T4:
P0.001; no exclusions: 7 cells removed, n 69 remaining; T3:
231°  8°, T4: 276°  11°; Moore: R
  2.54, p  0.001; phase
concentrationT3: p 0.001, T4: p 0.001, Rayleigh test). In the
familiar environment, scopolamine induced a significant co-
herent phase change to a phase 	45–50° earlier than baseline
(all pyramidal layer-referenced: 22 cells removed, n  43 re-
maining; T3: 243° 7°, T4: 198° 6°; Moore: R
  2.46, p
0.001; phase concentration T3: p 0.001, T4: p 0.001; no
exclusions: 27 cells removed, n  49 remaining; T3: 248° 
10°, T4: 197°  6°; Moore: R
  2.59, p  0.001; phase con-
centration T3: p 0.001, T4: p 0.001). The distribution of
cells’ preferred phases was different across the baseline trial
and the novel environment under scopolamine, but there was
no coherent change in phase: phase distribution in the
novelty-plus-scopolamine trial did not differ from a uniform
distribution (all pyramidal layer-referenced: 13 cells removed,
n  27 remaining; T3: 254°  17°, T4: 134°  36°; Moore: R’
 1.46, p 0.005; phase concentration T3: p 0.005, T4: p
0.29; ‘no exclusions’: 29 cells removed, n  51 remaining; T3:
274°  14°, T4: 3°  34°; Moore: R
  1.73, p  0.001; phase
concentration T3: p  0.001, T4: p  0.24).
In sum, the drop in spatial peak firing rate that occurs
under both novelty and scopolamine is unlikely to explain the
bidirectional phase changes elicited by these manipulations,
nor the disruption by scopolamine of the coherent shift to a
later phase in environmental novelty characteristic of the un-
drugged state.
The effect of running speed on phase was also investigated
because higher running speeds tend to drive higher firing rates
(Hirase et al., 1999; Geisler et al., 2007), and thus might be
thought, under some models (Harris et al., 2002; Mehta et al.,
2002), to drive earlier phases. However, the earlier phase in the
familiar environment under scopolamine accompanied speed re-
duction (T3: 20.9 1.4 cm/s; T4: 13.4 1.8 cm/s; paired t(3)
6.12, p  0.009), contrary to such an expectation. Further, the
phase in the novel environment under saline was later despite no
change in speed (T3: 18.9 1.4 cm/s; T4: 19.1 1.7 cm/s; paired
t(5)  0.12, p  0.91). Under scopolamine, novelty induced a
nonsignificant speed reduction (T3: 19.1 1.5 cm/s; T4: 16.8
1.6 cm/s; paired t(4)  0.86, p  0.44) while phase change was
variable and if anything earlier. In summary, neither firing rate
nor running speed is likely to account for the observed bidirec-
tional phase changes.
Scopolamine impairs the encoding of novel
spatial representations
What kind of changes in spatial firing patterns accompanied the
observed firing phase changes? ACh-based models of encoding
versus retrieval scheduling predict that scopolamine impairs en-
coding. Applied to spatial representations, the prediction is thus
that scopolamine should impair the emergence of a distinct spa-
tial map in a novel environment (i.e., scopolamine should reduce
levels of novelty-elicited remapping).We used population vector
analysis of spatial firing ratemaps to calculate a “spatial similarity
score” for the place cell ensembles. We first describe results using
cells from the best pyramidal layer-referenced ensembles, then
summarize very similar results obtained using all available cells.
Figure 7A shows that spatial firing patterns across the two pre-
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manipulation baseline trials (T2 vs T3)
were very stable, and nearly identically so,
in the four sessions (all four session T2 vs
T3 r values between 0.92  0.01 and
0.94  0.01), providing a good baseline
against which to measure changes.
Saline injection in the familiar envi-
ronment did not have a significant effect
on spatial map stability (Fig. 7A; T3 vs T4:
0.93  0.01; T2 vs T3 vs T3 vs T4, paired
t(3)  1.71, p  0.19): the place fields in
the familiar environment remained very
similar before and after saline. Scopol-
amine in the familiar environment mod-
estly reduced spatial reproducibility (Fig.
7A; T3 vs T4: 0.74 0.04; T2 vsT3 vsT3 vs
T4, paired t(3)  5.90, p  0.01), in line
with previous observations (Brazhnik et
al., 2003, 2004). Of particular interest here
was the effect of novelty. As expected, the
novelty manipulation under saline elic-
ited strong remapping (Fig. 7A; T4 vs T3: 0.38 0.06; T2 vs T3 vs
T3 vs T4, paired t(5)  10.88, p  0.001). Interestingly, novelty
also elicited remapping under scopolamine, but to a lesser extent
(Fig. 7A; T4 vs T3: 0.52 0.04; T2 vs T3 vs T3 vs T4: paired t(4)
10.32, p  0.001). We quantified the differences between the
three noncontrol manipulations that reduced spatial similarity
(i.e., excluding FAM SAL) by calculating the baseline-to-probe
spatial similarity reduction (i.e., spatial similarity score of T2 vs
T3 minus spatial similarity score of T3 vs T4) for the four rats
tested in all three testing conditions. The reduction in spatial
similarity was strongest for novelty under saline (0.55  0.07),
moderate for novelty under scopolamine (0.39 0.05), and mi-
nor for scopolamine in the familiar environment (0.18  0.03),
with each condition significantly different from each other
(ANOVARM: F(1.02,3.06) 37.36, p 0.008; ps0.01 for all post
hoc LSD comparisons). As Figure 7B shows, the amount of
novelty-elicited remapping was lower under scopolamine in each
of the five rats tested in both novelty conditions (paired t(4) 
4.58, p 0.01).
[Similar results were seen in analyses when all cells were in-
cluded: (1) all rats, condition-by-condition: FAM SAL (T2 vs
T3: 0.92  0.002, T3 vs T4: 0.92  0.01; paired t(3)  0.49, p 
0.66); FAM SCOP (T2 vsT3: 0.92 0.01, T3 vsT4: 0.75 0.07;
paired t(3) 5.99, p 0.009);NOV SAL (T2 vs T3: 0.92 0.01;
T3 vs T4: 0.34 0.04; paired t(5) 14.15, p 0.001); NOV
SCOP (T2 vs T3: 0.92 0.01, T3 vs T4: 0.49 0.06; paired t(4)
7.43, p  0.001); (2) reduction in spatial similarity for four rats
common to noncontrol conditions: NOV  SAL (0.60  0.06);
NOV SCOP (0.39 0.08), FAM SCOP (0.17 0.03); ANO-
VARM: F(2,6)  39.76, p  0.001; ps 0.04 for all post hoc LSD
comparisons; and (3) reduction in spatial similarity for rats tested
in both novelty conditions: NOV  SAL: 0.58  0.04; NOV 
SCOP: 0.43 0.06; paired t(5) 3.2, p 0.02.)
In summary, upon exposure to novel environments, sco-
polamine significantly attenuated the distinctiveness of the
spatial code for the new environment compared with the code
for the familiar environment. This is clearly consistent with
models of ACh’s role in biasing encoding versus retrieval dy-
namics toward new encoding (Hasselmo et al., 1996; Meeter et
al., 2004), and muscarinic cholinergic blockade antagonizing
this effect.
Spatial information was reduced under scopolamine but this
was not linked to impaired remapping in the novel
environment
The results reported in the section above showed that, relative to
saline injection, scopolamine injection decreased spatial repro-
ducibility in the familiar environment and increased spatial re-
producibility in the novel environment. We considered if this
could be linked to scopolamine reducing the spatial locational
information carried by the cells. For instance, it could be that
more out-of-field firing under scopolamine would lower spatial
reproducibility in the familiar environment and increase spatial
reproducibility in the novel environment (assuming novelty-
elicited remapping). This hypothesized link makes two direc-
tional predictions. The first prediction is that in the familiar-to-
familiar environment condition (FAM  SCOP), the
degradation in spatial information (T3 T4 values) will be neg-
atively correlatedwith spatial reproducibility. The second predic-
tion is that in the familiar-to-novel environment condition
(NOV  SCOP), T3 T4 spatial information will be positively
correlated with spatial reproducibility. If the second prediction is
met, this would cast some doubt on the theoretical interpretation
that ACh dampens novelty-elicited encoding.
We first tested if scopolamine reduces spatial information.We
calculated spatial (locational) information in bits per spike in
firing ratemaps corrected for inhomogeneous sampling (Burgess
et al., 2005). Saline did not significantly affect spatial information
in either the familiar or novel environment (bits/spike: FAM 
SAL: all cells: T3: 1.34  0.07, n  64, T4: 1.25  0.09, n  63,
t(125)  0.76, p  0.45; theta-modulated cells 50 spikes: T3:
1.29  0.07, n  58, T4: 1.19  0.08, n  58, t(114)  0.92, p 
0.36; NOV SAL: all cells: T3: 1.62 0.07, n 196, T4: 1.80
0.10, n  193, t(340)  1.48, p  0.14; theta-modulated cells
50 spikes: T3: 1.28 0.06, n 130, T4: 1.13 0.06, n 124,
t(252) 1.92, p 0.06).
In contrast, scopolamine did reduce spatial information in
both familiar andnovel environments (bits/spike: FAMSCOP: all
cells:T3: 1.550.07,n122,T4:0.880.04,n121, t(194)8.22,
p 0.001; theta-modulated cells50 spikes: T3: 1.37 0.06, n
93, T4: 0.86 0.05, n 95, t(171) 6.61, p 0.001; NOV SCOP:
all cells: T3: 1.48 0.07, n 188, T4: 1.09 0.07, n 180, t(366)
3.77, p 0.001; theta-modulated cells50 spikes: T3: 1.15 0.06,
n  124, T4: 0.84  0.05, n  121, t(243)  4.02, p  0.001). In
Figure 7. Scopolamine attenuates the formation of distinct representations of new environments. A, The four testing condi-
tions differentially affect place cells’ environmental representations. Representations are very stable across premanipulation
baseline trials T2 and T3 for all four sessions, and do not change after saline injection in the familiar environment (FAM SAL).
Novelty induces strong remapping (i.e., low population-vector spatial similarity scores across T3 and T4) in the undrugged state
(NOV SAL), but this is attenuated by scopolamine (NOV SCOP). Scopolamine in the familiar environment (FAM SCOP) does
not induce remapping but modestly reduces spatial stability. For illustrative purposes, SEM error bars indicate the variance due to
the condition (T2 vs T3 or T3 vs T4); variance due to individual differences has been removed, as in Cousineau (2005). B, Scopol-
amine reduces the amount of novelty-elicited remapping (difference between spatial similarity scores [T2 vs T3] and [T3 vs T4]) in
each of the five rats tested in both environmental novelty sessions.
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summary, scopolaminedid reduce, but saline didnot reduce, spatial
information in both the familiar and novel environments.
To quantify spatial reproducibility, we used the spatial repro-
ducibility measure of Muller et al. (1987). It is less sensitive than
the population vector method, but can be used on a cell-by-cell
basis to test correlations between spatial information change and
spatial reproducibility. The first prediction to be tested was that
in the FAM  SCOP condition, T3  T4 spatial information
would be negatively correlated with spatial reproducibility. This
directional prediction received some support (all cells, No exclu-
sions: T3-T4 locational bits/spike vs T3 to T4 spatial reproduc-
ibility, r0.151, n 118, one-tailed p 0.05). This suggests
that degradation in the locational firing signal from the baseline
(T3) to the probe trial (T4) does contribute somewhat to lower-
ing the spatial similarity of the spatial maps in the FAM SCOP
condition.
The second prediction to be tested was that in the NOV 
SCOP condition, T3  T4 spatial information would be posi-
tively correlated with spatial reproducibility. This prediction was
not supported, r being nonsignificantly weakly negative (T3–T4
locational bits/spike vs T3 to T4 spatial reproducibility, r 
0.02, n 164, two-tailed p 0.79). Importantly, this suggests
that degradation in the locational firing signal from the baseline
(T3, familiar) to the probe trial (T4, novel) does not contribute to
T3 to T4 spatial reproducibility across those trials in the NOV
SCOP condition. In other words, as far as we can tell, the in-
creased spatial similarity of the spatial maps across the familiar
and novel environment under scopolamine, relative to under
saline, is probably not due to scopolamine-degraded spatial firing
boosting spatial reproducibility. Rather, this increased spatial
similarity appears to be due to scopolamine impairing the process
of novelty-elicited remapping.
Discussion
The present study is the first to show bidirectional changes of the
preferred theta phase of firing of CA1 pyramidal cells according
to predicted changes in the balance between encoding and re-
trieval. Theta-phase models (Hasselmo et al., 2002; Kunec et al.,
2005; Manns et al., 2007; Cutsuridis et al., 2010) imply that the
preferred firing phase over a given period reflects the ratio of
encoding and retrieval activity, with encoding preferentially oc-
curring at the theta peak and retrieval, at the trough. Here, we
specifically demonstrate, in line with these models, that the pre-
ferred firing phase shifts closer to the pyramidal-layer theta peak
during novelty, when encoding should prevail. This extends a
previous result (Lever et al., 2010), which did not use a consistent
theta reference (see also Poe et al., 2000; Manns et al., 2007).
Furthermore,wenowshowevidence for theAChmodels (Hasselmo
et al., 1996; Meeter et al., 2004) and their complementarity with
theta-phase models. Hasselmo et al. (1996) specifically predicted
that ACh would bias the encoding-retrieval dynamics toward
encoding, while cholinergic blockade would bias the dynamics
toward retrieval. This was shown in three effects, demonstrated
here for the first time, of injecting the nonselective muscarinic
antagonist scopolamine. Scopolamine attenuated the novelty-
elicited formation of a new spatialmap in a distinct environment,
as shown by impaired place-cell remapping in the novel environ-
ments; it shifted the preferred firing phase in a familiar environ-
ment toward the theta trough, associated with retrieval; and it
disrupted the coherent novelty-elicited shift of preferred phase
toward the theta peak.
One limitation of the present study is that, while encoding
likely prevails in novelty, and retrieval in familiarity, we have
inferred, rather than directly measured, encoding and retrieval
states. This caveat aside, our findings support predictions derived
from both the theta-phase and ACh-based models of encoding
versus retrieval scheduling and thus support their integration
into a common framework (Barry et al., 2012; Easton et al., 2012;
Hasselmo, 2012).
Novelty and neuromodulation
Our experiment specifically tested the contribution of ACh to the
novelty response. Of course, other neuromodulators are released
in novelty, such as dopamine (Lisman and Grace, 2005) and nor-
adrenaline (Yu and Dayan, 2005). Thus, other neuromodulators
than ACh may also play a role, and interact with ACh, in the
responses to novelty observed here (preferred phase change, re-
mapping). We note that preferred phase in the novel environ-
ments after scopolamine injection was somewhat variable, and
that such variability was not seen in the familiar environment
after scopolamine injection. Why? Importantly, we saw no evi-
dence that theta-phase concentration was reduced by the
novelty-plus-scopolamine probe relative to the other three con-
ditions. Rather, the variability might result from the difficulty of
standardizing the latency of a drug’s peak effect in a specific brain
area following intraperitoneal injections. The variability in phase
change could arise from the variable latency of the scopolamine
peak with respect to the introduction of environmental novelty,
and thus with respect to the release of novelty-elicited neuro-
modulators. The variable relative latency of the scopolamine
peak and neuromodulator-release peak may be critical as the
interaction between neuromodulators can be quite complex. For
example, acetylcholine and noradrenaline can have antagonistic
interactions (Yu and Dayan, 2005). Their antagonistic action in
the hippocampal response to novelty has been observed in
rearing-on-hind-legs behavior (Lever et al., 2006).Whenmusca-
rinic or -adrenergic agonists are infused alone into the dentate
gyrus, rearing substantially increases; however, when they are
co-infused, rearing does not increase (Flicker and Geyer, 1982).
In summary, muscarinic antagonismmay have somewhat differ-
ent effects when peaking before and after the novelty-elicited
neuromodulator release peak.
Overall, however, despite some variability, a common result
emerged from the novelty-plus-scopolamine condition; the
later-theta-phase-in-novelty effect was clearly disrupted. Thus a
conjoint prediction obtained from the theta-phase and ACh
models was confirmed. ACh should shift the encoding-retrieval
dynamics toward encoding (i.e., nearer pyramidal theta peak
phase), and an anti-muscarinic drug should disrupt this shift
toward encoding, as observed here.
Mechanisms underlying the later-theta-phase-in-novelty
effect and its disruption
Together, our results demonstrate that ACh at least partly drives
the later-theta-phase-in-novelty effect (i.e., the encoding-related
shift of CA1 preferred phase toward the pyramidal-layer theta
peak in novelty). This could be tested in future work by, for
instance, enhancing cholinergic transmission in a familiar envi-
ronment, and seeing if this elicits a later preferred theta phase of
CA1 firing. Although the predictions of the ACh model (Has-
selmo et al., 1996) confirmed in the present study were based
specifically onACh’s presynaptic suppression of CA3’s excitatory
input onto CA1 pyramidal neurons (Hasselmo and Schnell,
1994), we cannot be certain of the neural sites underlying our
effects, since we used systemic muscarinic blockade. Coordina-
tion of the later-theta-phase-in-novelty effect and thus encoding
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versus retrieval scheduling may also involve interneurons, which
strongly influence the rhythmicity of pyramidal cells (Buzsa´ki,
2002; Freund and Katona, 2007; Klausberger and Somogyi,
2008). For example, parvalbumin-expressing interneurons influ-
ence pyramidal theta phase during phase precession (Royer et al.,
2012) and some of these interneurons express muscarinic recep-
tors (Ha´jos et al., 1998). ACh alters the coupling between pyra-
midal cells and interneurons (Pitler and Alger, 1992; Patil and
Hasselmo, 1999; Brazhnik et al., 2003). Finally, changes of pre-
ferred theta phase in CA1 could also reflect upstream changes,
such as in CA3. Interestingly, a theta phase-based modulation of
afferent inputs to CA3 has been shown during novelty, an effect
disrupted by cholinergic antagonism (Villarreal et al., 2007).
These issues can be explored in future work using multisite re-
cordings of principal cells and interneurons across entorhinal
cortex, CA3, and CA1 (Mizuseki et al., 2009).
Place-cell remapping is a well established phenomenon and is
related to encoding a representation of a new environment
(Muller and Kubie, 1987; Kentros et al., 1998; Lever et al., 2002;
Leutgeb et al., 2004; Wills et al., 2005; Fyhn et al., 2007; McHugh
et al., 2007; Sava and Markus, 2008; Nakashiba et al., 2012). As
our phase results with scopolamine suggest (shift toward theta
trough in familiar environment and disruption of the later-phase-
in-novelty effect), scopolamine may have reduced novelty-elicited
remapping by setting the encoding-retrieval dynamics toward re-
trieval. This is compatible with results following selective lesion of
the cholinergic input to the hippocampus (Ikonen et al., 2002),
whereby place cells initially remapped in a novel environment, but
converged over a few trials toward the patterns observed in the
familiar environment. Our data are also consistent with the
observation that scopolamine reduces hippocampal expres-
sion of immediate early genes following environmental nov-
elty (Wirtshafter, 2005).
Functional implications: two complementary mechanisms of
encoding versus retrieval scheduling
We refer to the theta-phase and ACh-based models of Meeter et
al. (2004), Easton et al. (2012), andHasselmo (2012) asmodels of
encoding versus retrieval scheduling. Both sets of models instan-
tiate solutions to proactive interference, a potentially ubiquitous
problem occurring when a previous association with a cue inter-
feres with encoding a new association with that cue. Broadly
speaking, in both sets of models, appropriate synaptic plasticity
regimes are scheduled for each state: long-term synaptic
strengthening for encoding, but not for retrieval (Hasselmo,
2012), and encoding and retrieval states are separated so that
retrieval of prior associations does not interfere with encoding
new associations.
A potential limitation of ACh-based encoding versus retrieval
scheduling is ACh’s slow action, and thus the relatively slow tran-
sition between pro-encoding and pro-retrieval states. In the
theta-based models, the alternation of these states occurs much
more rapidly. It is likely adaptive that the hippocampus uses both
mechanisms of encoding versus retrieval scheduling, with their
different timescales of action. Our data are clearly consistent with
bothmodels, since we used these models to make the predictions
supported here as follows: (1) preferred phase shifts closer to the
pyramidal-layer theta peak in novelty, when encoding prevails;
(2) this encoding-related shift is disrupted by scopolamine, sug-
gesting that ACh partly drives it; (3) scopolamine in a familiar
environment shifts preferred phase closer to the pyramidal-layer
theta trough, consistent with low ACh levels biasing encoding-
retrieval dynamics away from encoding toward retrieval; and (4)
scopolamine reduces novelty-elicited remapping, consistent with
low ACh levels biasing encoding-retrieval dynamics away from
encoding. In summary, cholinergic-based and theta-basedmech-
anisms are likely complementary means of biasing activity to-
ward encoding or retrieval in the hippocampus.
There is direct evidence for encoding versus retrieval biasing
at longer and shorter timescales. Briefly, longer timescale encod-
ing versus retrieval biasing, consistent with cholinergic action, is
seen by (Duncan et al., 2012), which showed that pattern separa-
tion (implying a pro-encoding bias) was enhanced if preceded by
0.5 s by a novel stimulus, but not by a familiar stimulus. Evidence
for rapid, theta-paced encoding versus retrieval scheduling was
seen inCA3place cells flickering between distinct representations
of two environments (Jezek et al., 2011). Transitions between
representations tended to occur at a particular theta phase, and
attractor-based retrieval activity appeared dominant in one-half
of the theta cycle.
In summary, our results strongly suggest that both theta phase
and ACh are involved in temporal scheduling of encoding versus
retrieval in CA1, and form part of the neural mechanisms for
counteracting proactive interference, a classic problem for
memory.
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